146 related articles for article (PubMed ID: 2744929)
1. Limitations of diet therapy in patients with non-insulin-dependent diabetes mellitus.
Wolffenbuttel BH; Weber RF; Van Koetsveld PM; Verschoor L
Int J Obes; 1989; 13(2):173-82. PubMed ID: 2744929
[TBL] [Abstract][Full Text] [Related]
2. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.
Watts NB; Spanheimer RG; DiGirolamo M; Gebhart SS; Musey VC; Siddiq YK; Phillips LS
Arch Intern Med; 1990 Apr; 150(4):803-6. PubMed ID: 2327840
[TBL] [Abstract][Full Text] [Related]
3. [The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus].
Sindelka G; Skrha J; Hilgertová J; Justová V
Cas Lek Cesk; 1997 Sep; 136(17):530-2. PubMed ID: 9441013
[TBL] [Abstract][Full Text] [Related]
4. The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes.
Bi Y; Tong GY; Yang HJ; Cai MY; Ma JH; Liang J; Xin B; Miao H; Peng ZH; Zhu DL
Diabetes Metab Res Rev; 2013 Nov; 29(8):664-72. PubMed ID: 23955995
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
Low CC; Grossman EB; Gumbiner B
Diabetes; 1996 May; 45(5):569-75. PubMed ID: 8621005
[TBL] [Abstract][Full Text] [Related]
6. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
7. Three months energy restricted diet does not reduce peripheral insulin resistance in newly diagnosed non insulin dependent diabetics.
Walshe K; Andrews WJ; Sheridan B; Woods R; Hadden DR
Horm Metab Res; 1987 May; 19(5):197-200. PubMed ID: 3556373
[TBL] [Abstract][Full Text] [Related]
8. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a carbohydrate-free diet vs. fasting on plasma glucose, insulin and glucagon in type 2 diabetes.
Nuttall FQ; Almokayyad RM; Gannon MC
Metabolism; 2015 Feb; 64(2):253-62. PubMed ID: 25458830
[TBL] [Abstract][Full Text] [Related]
10. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
11. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients.
Furuta M; Tamai M; Hanabusa T; Yamamoto Y; Nanjo K; Sanke T
Diabetes Res Clin Pract; 2006 Jun; 72(3):302-7. PubMed ID: 16442181
[TBL] [Abstract][Full Text] [Related]
13. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
14. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
[TBL] [Abstract][Full Text] [Related]
15. Added benfluorex in obese insulin-requiring type 2 diabetes.
Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
[TBL] [Abstract][Full Text] [Related]
16. Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus.
Blaha V; Musil F; Smahelova A; Ticha A; Hyspler R; Haluzik M; Lesna J; Sobotka L
Neuro Endocrinol Lett; 2012; 33 Suppl 2():6-12. PubMed ID: 23183502
[TBL] [Abstract][Full Text] [Related]
17. Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucose.
Rave K; Roggen K; Dellweg S; Heise T; tom Dieck H
Br J Nutr; 2007 Nov; 98(5):929-36. PubMed ID: 17562226
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance.
Taha D; Umpaichitra V; Banerji MA; Castells S
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):135-42. PubMed ID: 16562586
[TBL] [Abstract][Full Text] [Related]
19. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus.
Henry RR; Scheaffer L; Olefsky JM
J Clin Endocrinol Metab; 1985 Nov; 61(5):917-25. PubMed ID: 4044780
[TBL] [Abstract][Full Text] [Related]
20. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
Henry RR; Brechtel G; Griver K
J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
